Atrium Therapeutics, Inc.
$7.67
-0.15 (-1.92%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -19.8%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -47.5%
Own RNA?
See how RNA contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.